Breaking News Instant updates and real-time market news.

ADHD

Alcobra

$1.21

0.08 (7.08%)

08:50
06/12/17
06/12
08:50
06/12/17
08:50

Alcobra announces cooperation agreement with Brosh Group

Alcobra announced that it has entered into a cooperation agreement with Brosh Capital Partners L.P. and certain of its affiliates in connection with, among other things, Alcobra's 2017 Annual General Meeting of Shareholders. Pursuant to the Cooperation Agreement, Alcobra has appointed two new directors, Amir Efrati and Yuval Yanai, to the Alcobra board, effective immediately. Yanai is not affiliated with the Brosh Group and qualifies as an independent director. As of the appointments, the Alcobra board consists of ten directors. The Cooperation Agreement also provides that Alcobra will continue its ongoing review of strategic alternatives and existing proposals by inviting additional proposals from targeted candidates and conducting diligence on several additional prospects. The parties have also agreed that the company's upcoming AGM, previously scheduled to occur by July 20, 2017, will be postponed until September 1, 2017, and, if needed, further postponed as long as Alcobra's strategic review process is ongoing and satisfactory to both parties.

ADHD Alcobra
$1.21

0.08 (7.08%)

02/08/17
02/08/17
UPGRADE
Target $4

Buy
Alcobra upgraded to Buy at Roth Capital
As previously reported, Roth Capital analyst Michael Higgins upgraded Alcobra to Buy from Neutral after the company introduced ADAIR, or Abuse Deterrent, Amphetamine Immediate Release, to address the diversion and abuse problem with ADHD medications. With $50M in cash to start 2017, the analyst believes Alcobra is well-funded. He also raised his price target on the shares to $4 from $1.
02/08/17
ROTH
02/08/17
UPGRADE
Target $50
ROTH
Buy
Alcobra upgraded to Buy from Neutral at Roth Capital
01/18/17
JEFF
01/18/17
DOWNGRADE
Target $1.25
JEFF
Hold
Alcobra downgraded to Hold from Buy at Jefferies
Jefferies analyst Biren Amin downgraded Alcobra to Hold and lowered its price target following the announcement that the MEASURE study in adult ADHD failed to meet its primary endpoint. Amin lowered Alcobra's price target to $1.25 from $6.
01/17/17
ROTH
01/17/17
DOWNGRADE
Target $1
ROTH
Neutral
Alcobra downgraded to Neutral from Buy at Roth Capital
Roth Capital analyst Michael Higgins downgraded Alcobra to Neutral from Buy after the company announced that the partially-enrolled Phase 3 MEASURE trial failed to meet primary endpoint. The analyst also lowered his price target on the shares to $1 from $7.50.

TODAY'S FREE FLY STORIES

INTU

Intuit

$157.78

1.23 (0.79%)

16:12
11/20/17
11/20
16:12
11/20/17
16:12
Earnings
Intuit sees Q2 adjusted EPS 31c-34c, consensus 32c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

PANW

Palo Alto Networks

$142.61

-0.115 (-0.08%)

16:12
11/20/17
11/20
16:12
11/20/17
16:12
Earnings
Palo Alto Networks sees Q2 adjusted EPS 78c-80c, consensus 77c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 11

    Dec

  • 11

    Dec

  • 17

    Jan

  • 17

    Jan

RVNC

Revance

$24.60

-1.35 (-5.20%)

16:11
11/20/17
11/20
16:11
11/20/17
16:11
Hot Stocks
Revance: FDA grants orphan drug designation for RT002 »

Revance Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

PANW

Palo Alto Networks

$142.24

-0.48 (-0.34%)

16:10
11/20/17
11/20
16:10
11/20/17
16:10
Earnings
Palo Alto Networks reports Q1 adjusted EPS 74c, consensus 69c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 11

    Dec

  • 11

    Dec

  • 17

    Jan

  • 17

    Jan

INTU

Intuit

$157.78

1.23 (0.79%)

16:09
11/20/17
11/20
16:09
11/20/17
16:09
Earnings
Intuit reports Q1 adjusted EPS 11c, consensus 5c »

Reports Q1 revenue $886M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

A

Agilent

$70.00

1.205 (1.75%)

16:08
11/20/17
11/20
16:08
11/20/17
16:08
Earnings
Agilent sees FY18 adjusted EPS $2.50-$2.56, consensus $2.59 »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 30

    Nov

MHK

Mohawk

$276.40

4.2 (1.54%)

16:08
11/20/17
11/20
16:08
11/20/17
16:08
Hot Stocks
Mohawk to acquire Godfrey Hirst Group, terms not disclosed »

Mohawk Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

A

Agilent

$69.96

1.17 (1.70%)

16:07
11/20/17
11/20
16:07
11/20/17
16:07
Earnings
Agilent sees Q1 adjusted EPS 55c-57c, consensus 60c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 30

    Nov

CLSN

Celsion

$2.14

0.14 (7.00%)

16:07
11/20/17
11/20
16:07
11/20/17
16:07
Initiation
Celsion initiated  »

Celsion initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$28.27

0.37 (1.33%)

16:07
11/20/17
11/20
16:07
11/20/17
16:07
Earnings
Urban Outfitters reports Q3 EPS 41c, consensus 33c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

VIPS

Vipshop

$9.25

-0.53 (-5.42%)

16:07
11/20/17
11/20
16:07
11/20/17
16:07
Earnings
Breaking Earnings news story on Vipshop »

Vipshop sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

A

Agilent

$69.92

1.125 (1.64%)

16:06
11/20/17
11/20
16:06
11/20/17
16:06
Earnings
Agilent reports Q4 adjusted EPS 67c, consensus 62c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 30

    Nov

VIPS

Vipshop

$9.27

-0.51 (-5.21%)

16:06
11/20/17
11/20
16:06
11/20/17
16:06
Earnings
Vipshop reports Q3 adjusted EPS 14c, consensus 14c »

Reports Q3 revenue $2.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ARNC

Arconic

$23.87

0.02 (0.08%)

16:05
11/20/17
11/20
16:05
11/20/17
16:05
Hot Stocks
Arconic to install new horizontal heat treat furnace at Davenport Works facility »

Arconic announced plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIFI

SI Financial

$14.95

0.35 (2.40%)

16:04
11/20/17
11/20
16:04
11/20/17
16:04
Hot Stocks
SI Financial Chief Credit Officer Gerald Coia to retire »

SI Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTA

Enanta

16:03
11/20/17
11/20
16:03
11/20/17
16:03
Earnings
Enanta Pharmaceuticals reports Q4 EPS $1.86, consensus $2.13 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NBIX

Neurocrine

, ZBH

Zimmer Biomet

$112.03

0.42 (0.38%)

16:02
11/20/17
11/20
16:02
11/20/17
16:02
Hot Stocks
Neurocrine names Matt Abernethy as CFO »

Neurocrine Biosciences…

NBIX

Neurocrine

ZBH

Zimmer Biomet

$112.03

0.42 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 01

    Dec

  • 14

    Dec

CAFD

8point3 Energy

$14.94

0.04 (0.27%)

, PEGI

Pattern Energy

$22.13

0.14 (0.64%)

15:46
11/20/17
11/20
15:46
11/20/17
15:46
Periodicals
8point3 draws interest from Capital Dynamics, Pattern Energy, Bloomberg says »

Capital Dynamics and…

CAFD

8point3 Energy

$14.94

0.04 (0.27%)

PEGI

Pattern Energy

$22.13

0.14 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

VRX

Valeant

$15.64

0.95 (6.47%)

15:40
11/20/17
11/20
15:40
11/20/17
15:40
Options
Valeant calls active as shares see relative strength »

Valeant calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Jun

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

, GIS

General Mills

$54.23

0.51 (0.95%)

15:34
11/20/17
11/20
15:34
11/20/17
15:34
Periodicals
General Mills, not Nestle, should buy Hain Celestial, Cramer says »

Following a Bloomberg…

HAIN

Hain Celestial

$39.84

1.35 (3.51%)

GIS

General Mills

$54.23

0.51 (0.95%)

NSRGY

Nestle

$85.11

0.7 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$156.55

0.9 (0.58%)

15:34
11/20/17
11/20
15:34
11/20/17
15:34
Options
Intuit options imply 5.7% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

SHPG

Shire

$147.37

2.74 (1.89%)

, RHHBY

Roche

$29.10

0.205 (0.71%)

15:32
11/20/17
11/20
15:32
11/20/17
15:32
Recommendations
Shire, Roche analyst commentary  »

Shire selloff on Roche…

SHPG

Shire

$147.37

2.74 (1.89%)

RHHBY

Roche

$29.10

0.205 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

15:30
11/20/17
11/20
15:30
11/20/17
15:30
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

TWX

Time Warner

$87.93

-0.79 (-0.89%)

15:28
11/20/17
11/20
15:28
11/20/17
15:28
Technical Analysis
Technical View: Time Warner drops on pending antitrust briefing »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$34.74

0.23 (0.67%)

, TWX

Time Warner

$87.93

-0.79 (-0.89%)

15:28
11/20/17
11/20
15:28
11/20/17
15:28
Periodicals
DOJ antitrust announcement concerns AT&T, Time Warner, NBC reports »

Bloomberg also reported…

T

AT&T

$34.74

0.23 (0.67%)

TWX

Time Warner

$87.93

-0.79 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.